Clinical Trial Update: Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis [NA]

View source ↗

Summary

Cardiawave SA completed a first-in-human study of Valvosoft for severe symptomatic aortic valve stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• VALVOSOFT

Snippet

Sponsor: Cardiawave SA | Conditions: Aortic Valve Stenosis | NA | Status: COMPLETED